Longevity company builder Maximon spawns new venture that aims to make longevity diagnostics and treatments more accessible.
Longevity clinic brand AYUN has opened its flagship clinic in Zurich with a mission to make comprehensive longevity diagnostics and treatments more accessible. As the latest venture to emerge from the stable of longevity builder Maximon, the clinic aims to helping individuals live healthier, longer lives by empowering them to take control of their health through data-driven methods.
The onset of chronic illness often significantly reduces quality of life during the later years of our lives, but AYUN is leveraging advances in diagnostics and treatments that offer the potential to address risk factors for age-related diseases early on. The clinic’s model emphasizes that maintaining good health into old age is not solely a matter of genetics, and that lifestyle choices also play a significant role.

AYUN’s services go beyond managing symptoms, aiming to extend the period in which people can live free from serious health problems. The clinic focuses on personalizing healthcare, analyzing an individual’s unique genetic, biological and lifestyle factors to develop tailored plans that include nutrition, exercise, supplements and longevity treatments. These plans are designed in close collaboration with personal goals to ensure relevance and effectiveness.
“We empower our customers to take their health and well-being into their own hands,” said Dr Leonie Bode, co-founder and Medical Director of AYUN. “We support them with advanced, scientifically validated methods to ensure a personalized approach at all times.”

At its central Zurich location, AYUN offers a comprehensive range of data-driven diagnostics and treatments. The clinic’s team includes specialists across various fields, including physicians, sports scientists and nutritionists, working together to provide personalized preventive healthcare. These services are rooted in evidence-based practices, ensuring that every intervention is scientifically validated. AYUN’s diagnostic services cover a wide spectrum, including blood tests, DNA analysis, cardiovascular assessments and physiological tests to evaluate factors like endurance, strength and stability.
“Bringing established longevity science into clinical practice is an ambitious ambition but necessary to make longevity tangible for patients,” said Maximon co-founder Marc Bernegger, who teased the launch of AYUN in a recent interview with Longevity.Technology.
In addition to diagnostics, the clinic offers individualized health and longevity reports. From these assessments, personalized treatment plans are developed, focusing on interventions like hyperbaric oxygen therapy, altitude training, red light therapy and IV nutritional supplements.

AYUN also offers digital health data management, enabling patients to track their health and treatment plans through a dedicated web app. The clinic says its early offerings were met with high demand, with pre-launch packages selling out quickly.
With an approach that emphasizes prevention and early intervention, the clinic aims to expand beyond Switzerland into Europe and the Middle East by 2025.
“The demand from customers in Switzerland, but also from customers and investors abroad, confirms that we are on the right track,” said Vincent Aebi, Co-Founder and COO of AYUN. “Accordingly, we are already at an advanced stage of planning our expansion.”


